. PLCG2 Protective Variant p.P522R Modulates Tau Pathology and Disease Progression in Patients with Mild Cognitive Impairment. The Lancet Preprints, December 29, 2018; posted January 2, 2019. Retrieved from https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3307649


Kleineidam, L., Chouraki, V., Próchnicki, T., van der Lee, S., Madrid-Márquez, L., Wagner-Thelen, H., … Ramirez, A.


Please login to recommend the paper.


No Available Comments

Make a Comment

To make a comment you must login or register.